Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
$241.56
+1.2%
$296.43
$100.02
$452.70
$255.04B3.95.24 million shs3.49 million shs
ArcelorMittal stock logo
MT
ArcelorMittal
$73.51
+1.2%
$67.60
$31.93
$75.66
$56.30B1.531.51 million shs1.09 million shs
Novartis AG stock logo
NVS
Novartis
$160.09
+1.3%
$154.66
$121.57
$170.46
$301.53B0.451.50 million shs998,151 shs
10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
+1.16%-4.64%-7.10%-20.20%+75.32%
ArcelorMittal stock logo
MT
ArcelorMittal
+1.20%+2.10%+9.80%+7.33%+116.86%
Novartis AG stock logo
NVS
Novartis
+1.32%+3.48%+3.39%+5.91%+27.95%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
$241.56
+1.2%
$296.43
$100.02
$452.70
$255.04B3.95.24 million shs3.49 million shs
ArcelorMittal stock logo
MT
ArcelorMittal
$73.51
+1.2%
$67.60
$31.93
$75.66
$56.30B1.531.51 million shs1.09 million shs
Novartis AG stock logo
NVS
Novartis
$160.09
+1.3%
$154.66
$121.57
$170.46
$301.53B0.451.50 million shs998,151 shs
10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
+1.16%-4.64%-7.10%-20.20%+75.32%
ArcelorMittal stock logo
MT
ArcelorMittal
+1.20%+2.10%+9.80%+7.33%+116.86%
Novartis AG stock logo
NVS
Novartis
+1.32%+3.48%+3.39%+5.91%+27.95%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
2.65
Moderate Buy$305.1326.31% Upside
ArcelorMittal stock logo
MT
ArcelorMittal
2.42
Hold$74.801.75% Upside
Novartis AG stock logo
NVS
Novartis
2.31
Hold$141.20-11.80% Downside

Current Analyst Ratings Breakdown

Latest MT, ARM, and NVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/25/2026
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
Reiterated RatingOutperform
8/25/2026
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
Set Price Target$641.00
8/24/2026
ArcelorMittal stock logo
MT
ArcelorMittal
Initiated CoverageOverweight$82.00
8/13/2026
ArcelorMittal stock logo
MT
ArcelorMittal
DowngradeBuy (B-)Hold (C)
8/5/2026
ArcelorMittal stock logo
MT
ArcelorMittal
Reiterated RatingOverweight
8/4/2026
ArcelorMittal stock logo
MT
ArcelorMittal
Reiterated RatingBuy
7/31/2026
ArcelorMittal stock logo
MT
ArcelorMittal
Reiterated RatingBuy (B-)
7/31/2026
ArcelorMittal stock logo
MT
ArcelorMittal
Reiterated RatingBuy$75.00
7/31/2026
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
Lower Price TargetBuy$270.00 ➝ $250.00
7/31/2026
ArcelorMittal stock logo
MT
ArcelorMittal
Boost Price TargetEqual Weight$62.00 ➝ $69.00
7/30/2026
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
UpgradeNeutralBuy$260.00
(Data available from 8/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
$4.92B52.44$1.12 per share216.54$8.08 per share29.90
ArcelorMittal stock logo
MT
ArcelorMittal
$61.35B0.93$7.68 per share9.57$73.32 per share1.00
Novartis AG stock logo
NVS
Novartis
$54.53B5.60$10.88 per share14.71$21.98 per share7.28
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
$904M$0.97249.03124.527.0820.25%12.24%9.41%11/4/2026 (Estimated)
ArcelorMittal stock logo
MT
ArcelorMittal
$3.15B$2.3631.159.930.542.88%4.20%2.42%11/5/2026 (Estimated)
Novartis AG stock logo
NVS
Novartis
$13.98B$6.6324.1516.322.7123.29%38.56%14.47%10/27/2026 (Estimated)

Latest MT, ARM, and NVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026Q1 2027
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
$0.40$0.45+$0.05$0.25$1.26 billion$1.29 billion
7/30/2026Q2 2026
ArcelorMittal stock logo
MT
ArcelorMittal
$1.18$0.90-$0.28$0.89$17.56 billion$16.76 billion
7/21/2026Q2 2026
Novartis AG stock logo
NVS
Novartis
$2.17$2.41+$0.24$1.71$14.07 billion$14.41 billion
6/30/2026Q2 2026
Novartis AG stock logo
NVS
Novartis
N/A$2.41N/A$1.71N/A$14.95 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
N/AN/AN/AN/AN/A
ArcelorMittal stock logo
MT
ArcelorMittal
$0.510.69%N/A21.61%N/A
Novartis AG stock logo
NVS
Novartis
$3.081.92%+5.28%46.46%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
N/A
5.25
5.25
ArcelorMittal stock logo
MT
ArcelorMittal
0.21
1.43
0.57
Novartis AG stock logo
NVS
Novartis
0.89
0.86
0.67

Institutional Ownership

CompanyInstitutional Ownership
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
7.53%
ArcelorMittal stock logo
MT
ArcelorMittal
9.29%
Novartis AG stock logo
NVS
Novartis
13.12%

Insider Ownership

CompanyInsider Ownership
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
N/A
ArcelorMittal stock logo
MT
ArcelorMittal
0.06%
Novartis AG stock logo
NVS
Novartis
0.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
9,5841.07 billionN/ANot Optionable
ArcelorMittal stock logo
MT
ArcelorMittal
125,554775.00 million774.54 millionOptionable
Novartis AG stock logo
NVS
Novartis
75,2671.91 billion1.91 billionOptionable

Recent News About These Companies

Zacks Research Issues Positive Outlook for Novartis Earnings
Dearborn Partners LLC Takes Position in Novartis AG $NVS
Novartis AG (NYSE:NVS) Receives Consensus Rating of "Hold" from Analysts
Novartis AG NVS Stock Forecast & Price Target
Novartis AG Sponsored ADR

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
ARM stock logo

ARM NASDAQ:ARM

$241.56 +2.78 (+1.16%)
Closing price 08/25/2026 04:00 PM Eastern
Extended Trading
$242.51 +0.95 (+0.39%)
As of 07:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

ArcelorMittal stock logo

ArcelorMittal NYSE:MT

$73.51 +0.87 (+1.20%)
Closing price 08/25/2026 03:59 PM Eastern
Extended Trading
$75.50 +1.98 (+2.69%)
As of 07:19 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ArcelorMittal S.A., together with its subsidiaries, operates as integrated steel and mining companies in the United States, Europe, and internationally. It offers semi-finished flat products, including slabs; finished flat products comprising plates, hot- and cold-rolled coils and sheets, hot-dipped and electro-galvanized coils and sheets, tinplate, and color coated coils and sheets; semi-finished long products, such as blooms and billets; finished long products consisting of bars, wire-rods, structural sections, rails, sheet piles, and wire-products; and seamless and welded pipes and tubes. The company also provides mining products, such as iron ore lumps, fines, concentrates, pellets, and sinter feeds; and coking coal. It sells its products to various customers in the automotive, appliance, engineering, construction, energy, and machinery industries through a centralized marketing organization, as well as distributors. The company has iron ore mining activities in Brazil, Bosnia, Canada, Liberia, Mexico, South Africa, and Ukraine. ArcelorMittal S.A. was founded in 1976 and is headquartered in Luxembourg City, Luxembourg.

Novartis stock logo

Novartis NYSE:NVS

$160.09 +2.07 (+1.31%)
Closing price 08/25/2026 03:59 PM Eastern
Extended Trading
$159.00 -1.09 (-0.68%)
As of 07:18 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.